Scandals involving price increases for prescription drugs have become increasingly common in the past five years. In 2015 there was widespread outrage when the drug Daraprim, a drug used to treat malaria and parasitic infections overnight, went from $13.50 a tablet to $750 a tablet. Similarly two whistleblowers exposed the practices of Questcor Pharmaceuticals, now Mallinckrodt, to […]
Categories: Quantitative
Continue Reading
